{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:36:53Z","timestamp":1769175413162,"version":"3.49.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.1007\/s40620-022-01406-w","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T08:17:04Z","timestamp":1659687424000},"page":"237-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist"],"prefix":"10.1093","volume":"36","author":[{"given":"Manuel","family":"Laslandes","sequence":"first","affiliation":[{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), Service de N\u00e9phrologie et Immunologie clinique, CHU Nantes, Nantes, France 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Connault","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France 2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Nicolet","sequence":"additional","affiliation":[{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), Service de N\u00e9phrologie et Immunologie clinique, CHU Nantes, Nantes, France 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ternisien","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie H\u00e9mostase, H\u00f4tel Dieu, CHU de Nantes, Nantes, France 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Gregoire","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, CHU Nantes, Nantes, France 4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Ville","sequence":"additional","affiliation":[{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), Service de N\u00e9phrologie et Immunologie clinique, CHU Nantes, Nantes, France 1"},{"name":"Center for Research in Transplantation and Translational Immunology, Nantes Universit\u00e9, INSERM, UMR 1064, Nantes, France 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Dantal","sequence":"additional","affiliation":[{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), Service de N\u00e9phrologie et Immunologie clinique, CHU Nantes, Nantes, France 1"},{"name":"Center for Research in Transplantation and Translational Immunology, Nantes Universit\u00e9, INSERM, UMR 1064, Nantes, France 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2164","authenticated-orcid":false,"given":"Christophe","family":"Masset","sequence":"additional","affiliation":[{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), Service de N\u00e9phrologie et Immunologie clinique, CHU Nantes, Nantes, France 1"},{"name":"Center for Research in Transplantation and Translational Immunology, Nantes Universit\u00e9, INSERM, UMR 1064, Nantes, France 5"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"2026012307481411100_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"key":"2026012307481411100_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ekir.2019.12.001","article-title":"A systematic review of prophylactic anticoagulation in nephrotic syndrome","volume":"5","author":"Lin","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026012307481411100_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral Apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"2026012307481411100_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.kint.2019.11.027","article-title":"Role of direct oral anticoagulants in patients with kidney disease","volume":"97","author":"Derebail","year":"2020","journal-title":"Kidney Int"},{"key":"2026012307481411100_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ekir.2018.02.010","article-title":"Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome","volume":"3","author":"Sexton","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2026012307481411100_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s11239-020-02092-w","article-title":"Albumin and bleed risk in rivaroxaban treated patients","volume":"50","author":"Wojakowski","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"2026012307481411100_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000381310","article-title":"Do not forget nephrotic syndrome as a cause of increased requirement of levothyroxine replacement therapy","volume":"4","author":"Benvenga","year":"2015","journal-title":"Eur Thyroid J"},{"key":"2026012307481411100_CR8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1172\/JCI108035","article-title":"Pharmacokinetics of drugs in patients with the nephrotic syndrome","volume":"55","author":"Gugler","year":"1975","journal-title":"J Clin Invest"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01406-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01406-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/36\/1\/237\/66555854\/joneph_36_1_1406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01406-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/36\/1\/237\/66555854\/joneph_36_1_1406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:48:16Z","timestamp":1769172496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/1\/237\/8304117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,8,5]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01406-w","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest to disclose for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data were extracted from the French DIVAT cohort (www.divat.fr, approved\u00a0by the CNIL, n\u00b0914184) which quality is validated by an annual cross-center audit. In order to\u00a0respect confidential medical information, all data were anonymized before analysis.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical\u00a0statement"}},{"value":"While written consent was waived due to the adverse outcome, the patient was informed about the clinical description of her situation and did not raise verbal opposition.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}